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PREFACE 
This study characterizes the effects of methoxyflurane anesthesia 
on renal concentrating ability and response to antidiuretic hormone 
<ADH) challenge in dogs under conditions of dehydration and 
overhydration. The information gained is useful in evaluating the 
renal functional status of research animals or clinical patients 
exposed to methoxyflurane anesthesia. 
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I would also like to thank Wendy Batey, Fred Frye and Shane 
Ehrhart for helping me <often on weekends) to do the research and Mike 
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INTRODUCTION 
The ability of the kidneys to resorb free water during periods of 
dehydration is important in their function of maintaining body water 
homeostasis. Hypotension and/or an increase in plasma osmolality 
results in increased release of antidiuretic hormone <ADH). 
Antidiuretic hormone binds to receptors in the collecting ducts and 
results in resorption of free water from the tubular lumen. This 
returns free water to the plasma and concentrates the urine. 
In 1979, Hardy and Osborne reported the mean maximal urine 
specific gravity <USG) of 20 dogs following water deprivation to be 
1.062 + 0.007 and suggested that the production of urine with a 
specific gravity of less than 1.048 when slight dehydration is 
detectable indicates nephron dysfunction. 3 In subsequent reports, 
Osborne and Polzin have suggested the more conservative limit of 1.030 
as the minimum USG indicating adequate renal function in the 
dog.' ' 2 This level has become widely accepted. 4 - 9 Therefore, 
dogs with norma 1 rena 1 concentrating abi 1 i ty are expected to excrete 
urine with a specific gravity of greater than or equal to 1.030 when 
mildly dehydrated. Dogs that excrete urine with an inappropriately 
low urine specific gravity <less than 1 .030) while dehydrated are 
considered to have decreased renal concentrating ability. 2 ' 5 
The most common cause of decreased renal concentrating abi 1 i ty is 
primary renal failure, however, there are other causes. Diabetes 
insipidus, Addison's disease, Cushing's disease, severe hyponatremia, 
pyometra, hepatic failure, postobstructive diuresis, 
deficiency, diuretics, alcohol and corticosteroids 5 'g 
2 
potassium 
a 11 can 
interfere with concentrating abi 1 i ty, even with norma 11 y functioning 
kidneys. It is important to recognize these exceptions since they do 
not involve renal pathology and, therefore, warrant a different 
treatment and prognosis. 
Methoxyflurane, halothane, and methohex ita 1 have been reported to 
inhibit ADH stimulated free water transport in vitro. 10 ' 25 These 
reports are based on studies using the toad urinary bladder as a model 
for the mammalian kidney collecting duct epithelium. Extrapolation of 
the results of these studies to in vivo clinical situations suggests 
another condition, anesthesia, which might cause decreased renal 
concentrating abi 1 i ty without rena 1 fa i 1 ure and, therefore, 1 ead to 
misdiagnosis if its effect is not considered. Supporting this are the 
results of studies which have shown transient polyuria in dogs 
following methoxyflurane anesthesia. 17 - 20 
However, reports of human clinical studies appear to contradict 
this premise. Studies of water loaded human volunteers demonstrated a 
marked antidiuresis, characterized by change from positive to negative 
free water clearance, a marked reduction in urine volume and an 
increase in urine osmolality <Uosm), following induction of 
anesthesia. 11 - 13 
The purpose of this study was to examine and characterize the 
effect of methoxyflurane anesthesia on the renal concentrating ability 
of the dog; specifically, to determine if methoxyflurane anesthesia 
causes decreased renal concentrating ability and, if it does, to 
3 
determine the magnitude and duration of this decrease, and its 
responsiveness to ADH administration. 
MATERIALS AND METHODS 
Five clinically normal adult intact male mongrel dogs weighing 15 
to 20 kg were obtained through the laboratory animal resources unit. 
The animals were determined to be healthy on the basis of physical 
examination, complete blood count <CBC), serum chemistry profile, 
urinalysis and demonstration of the ability to concentrate urine to a 
specific gravity of greater than 1.047 when water was withheld. They 
were housed in individual indoor runs and fed a commercial dry dog 
food. The study consisted of three phases. Animals were given a 
minimum of two weeks recovery between each phase of the experiment. A 
urinalysis was performed during the recovery period after phase 1 and 
phase 2 to monitor for signs of cystitis and/or pyelonephritis which 
might result from catheterization and to ensure continued ability to 
adequately concentrate urine. 
Phase 1: Urine concentrating ability of dehydrated animals during and 
following methoxyflurane anesthesia 
Water was withheld for 24 to 36 hours, as necessary, to result in 
the production of concentrated urine, and food was withheld the day of 
the procedure. A surgical plane of methoxyflurane anesthesia was 
induced by mask followed by tracheal intubation; the animals were 
placed in lateral recumbency on heating pads and covered to help 
maintain body temperature. Depth of anesthesia was assessed by 
corneal reflex, jaw tone and response to toe pinch. Body temperature 
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was monitored every hour. No fluids were administered. An 8- to 10-
french, rubber, urinary catheter was placed for the collection of 
urine samples; serum samples were obtained by jugular venipuncture. 
Serum and urine samples were collected prior to anesthesia <O time) 
and after 1, 2, 3, and 4 hrs of anesthesia. Following 4 hrs of 
anesthesia at a surgical plane, the dogs were allowed to recover from 
anesthesia. Serum and urine samples were obtained at 1, 8, and 24 hrs 
after cessation of anesthesia. 
Specific gravity, osmolality, creatinine <cr), sodium <Na+) and 
potassium (K+) were measured for each urine sample and Na+, K+, 
cr and osmo 1 a lity were determined for each serum samp 1 e. Fraction a 1 
excretion (Fe) of Na+ and K+ were calculated for each sample using 
the formula 
Frac. excretion(X)=[Xlurlnel[xlserumX[crlseruml[crlurlneXlOO. 
Whole blood (3 mls) was collected in EDTA tubes for CBCs at 0 time 
and at the end of the anesthetic period. In addition to the above 
tests, chemistry profiles were run on each dog at 0 time and at the 
end of 4 hrs of anesthesia. 
Specific gravity was determined by refractometry. Osmolality was 
determined using a Wescor DlOOb vapor pressure osmometer. Serum 
chemistry values were determined on a DuPont ACA2 automated clinical 
analyzer and CBCs were performed on a Coulter counter model S. 
Phase 2: ADH response test 
Animals were handled similarly to phase l, but the duration of 
anesthesia was extended and at the beginning of the fifth hour of 
anesthesia, an ADH response test was performed. The animal received 
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2.2 ml/kg (1 ml/lb) of a solution containing 5 units of ADH in one 
liter of 5% Dextrose for a total dose of ll microunits/kg (5 
microunits/lb) as suggested by Hardy 3 • This 5% dextrose/ADH 
solution was given as a constant drip over 60 minutes. Additional 
serum and urine samples were collected 30, 60, and 90 minutes after 
induction of the ADH drip and assayed for osmolality, Na', K+, Cr 
and specific gravity. 
Phase 3: FREE WATER CLEARANCE AND ADH RESPONSIVENESS BEFORE AND AFTER 
ANESTHESIA IN WATER LOADED DOGS 
Animals were given a rapid IV drip of 5% Dextrose until the urine 
specific gravity was 1.005 or less. At this time, the drip rate was 
slowed to and maintained at 2.2 ml/kg/hr (1 ml/lb/hr) for a period of 
60 minutes to ensure that USG remained less than 1.005. A presample 
was obtained by collecting all urine produced over a 15 minute period; 
a matching serum sample was taken in the middle of this period. A 
preanesthetic ADH response test was then begun. The rate of fluid 
administration remained 2.2 ml/kg/hr using the 5i'o dextrose/ADH 
solution. The 5% dextrose/ADH drip was maintained for hour 
delivering a dose of 11 microunits of ADH/kg (5 microunits/lb) similar 
to phase 2. Two 30 minute urine samples were collected during the 5% 
dextrose/ADH infusion; serum samples were collected with each of the 
urine samples. At the end of one hour of 5% dextrose/ADH infusion, 
the infusion of 5% dextrose alone was resumed and continued until USG 
returned to 1.005 or less. 
The animal was then anesthetized with methoxyflurane by mask, 
intubated, placed on a heating pad and covered. The urine, along with 
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a matched serum sample, was collected every thirty minutes for two 
hours. At the beginning of the third hour of anesthesia, the ADH 
challenge was repeated. Urine volume, specific gravity, osmolality, 
and serum osmolality were measured and free water clearance was 
calculated for each sample. Following phase three, the dogs were 
euthanatized and post-mortem examination including renal 
histopathology was performed. 
Mean USG, Uosm.and FeNa+ were compared for all time periods 
against the presample (Phase and 2) or against the maximal 
preanesthetic ADH challenge value <Phase 3) using a paired t-test 29 • 
RESULTS 
PHASE 1 : 
Urine specific gravity <USG) and urine osmolality <Uosm) 
decreased rapidly after induction of anesthesia. The decrease was 
statistically significant for both parameters after the first hr and 
continued to decrease during the 4 hr anesthetic period (figure 1). 
The mean USG and Uosm for the various time periods are given in 
Table I. The average USG at 4 hrs of anesthesia and at the hr post 
anesthetic period were both below l .030 <x=l .028 + 0.003; 
range=l .020-1.035 and X=l .026 + 0.003; range=1 .016-1.032, 
respectively). The USG of the 8 hr post anesthetic period samples 
<x=l.030 ~ 0.002; range=l .025-l .034) remained significantly lower than 
the preanesthesia samples <x=l .050 ~ 0.002; range=l.045-l .055), but by 
24 hrs post anesthesia, the difference was no longer statistically 
significant. The lowest urine specific gravity obtained was 1.016 in 
the l hr post anesthetic period sample. Presample urine osmolalities 
Ph••• 1 Chana•• in urine apacific 
gravity of dehydrated dogs during and 
following •ethoxyflurene aneatheaia 
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TABLE I 
CHANGES IN URINE CONCENTRATIONS IN DEHYDRATED DOGS DURING METHOXYFLURANE ANESTHESIA 
Phase One 
Time <hr) 
0 1 2 3 4a 5 12 28 
Variable 
USG MEAN 1 .050 1.037* 1 . 031 * 1. 032* 1.028* 1. 026* 1. 030* 1. 042 
s. E. 0.002 0.003 0.001 0.002 0.003 0.003 0.002 0.005 
Uosm MEAN 1908 1297* 1091* 1082* 816* 915* 11 02* 1577 
S. E. 110 87 53 132 146 119 94 164 
Phase Two 
Time <hr) 
0 1 2 3 4 5 12 28 
Variable 
USG MEAN 1 .058 1. 043* 1 . 039* 1 .033* 1 . 036* 1 . 036* 1.035* 1 . 034* 
S. E. 0.003 0.001 0.002 0.001 0.002 0.003 0.003 0.002 
Uosm MEAN 2094 1433* 1275* 1165* 1245* 1291* 1237* 1156* 
s. E. 120 88 64 84 124 11 7 109 91 
a=anesthesia ended after obtaining this sample. 
b=ADH challenge started after obtaining this sample. 
*=significantly lower than 0 time (p< .05) co 
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were all greater than 1700 <x=l908 ± 110; range=1726-2326). They 
dropped rapidly following anesthesia; the nadir <x=816 ± 146) being at 
the fourth hour of anesthesia. At this time, osmolality ranged from 
413 to 1153 mosm/liter. Following recovery from anesthesia, urine 
osmolality increased such that, by 24 hrs following anesthesia it was 
no longer statistically different than preanesthesia sample values. 
Dog #1291 became markedly hyperkalemic <serum potassium 
concentration of 8.5 mEq/1) after 4 hrs of anesthesia. This was 
associated with a severe respiratory acidosis <venous pH= 6.94, 
Pcoz=l22.8, Poz=357, HC03=26.6 mEq/1). The serum K+ values of 
the other dogs remained within the normal range. 
Three of the five dogs became hypothermic <body temp. less than 
99°F). The other dogs maintained normal body temperature <100-103°F). 
PHASE 2: 
A significant drop in USG and Uosm was again seen following 
induction of anesthesia <Table I>. Mean USG was reduced from 1.058 + 
0.003 <range=l.053-1.068) prior to anesthesia to a nadir of 1.033 + 
0.001 <range=l.027-1.035) after three hrs of anesthesia. The mean 
osmolality dropped from 2094 ± 120; <range=l778-2560) to 1165 ± 84; 
<range=920-1427) at three hrs of anesthesia. There was no significant 
increase in USG or Uosm following administration of an ADH drip 
<Table I, Fig. 2). 
Dog #1291 became moderately hyperkalemic, again, with a serum K+ 
level of 7.88 mEq/L after three hours of anesthesia. Venous pH at 
this time was 7.08 with a PCOz of 84 and a bicarbonate of 25.3 
mEq/1. The serum K+ levels were within the normal range in the other 
i.OB!I 
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dogs, although most of the other dogs were mildly to moderately 
acidemic <venous pH range 7. 18-7.4). 
Two of the five dogs became hypothermic. 
PHASE 3: 
Results of phase 3 are given in Table II and Fig. 3. During the 
initial water load, the mean USG was 1.002 ±. 0.0005 <range=1.00l to 
1 .004) and the mean free water clearance was 3.4 + 0.9 ml/min 
<range= 1. 28-6. 89) As expected, the ADH cha 11 enge resulted in a marked 
increase in USG, drop in urine volume and conversion to negative free 
water clearance. During the second thirty minute collection period 
after the start of the ADH challenge, mean USG was 1.036 + 0.002 
<range=l.030-1.043) and the free water clearance was -0.71 + 0.35 
ml/min <range= -0.07to -2.12). Urine specific gravity decreased to 
1.001 + 0 and free water clearance increased to 2.99 ±. 0.42 ml/min 
<range=2.08 to 4.76) within 1 to 2 hrs after cessation of the ADH drip. 
Anesthesia resulted in changes similar to those seen during ADH 
challenge. One hour after induction of anesthesia, mean USG was 1.026 
±. 0.002 <range=l.020 to 1.030) and free water clearance was -0.52 ±. 
0.16 ml/min. (range=O.Ol to -1.04). The 90 and 120 minute values were 
not statistically different from those at one hour. 
The ADH challenge performed at the beginning of the third hour of 
anesthesia did not result in any statistically significant changes in 
USG, Uosm or free water clearance. 
The USG and Uosm from the ADH challenge performed during 
anesthesia were generally lower than the ADH challenge on 
unanesthetized dogs. Only one of the 5 dogs was able to attain USG 
TABLE II 
RESPONSE OF WATER LOADED DOGS TO ADH CHALLENGE 
BEFORE AND DURING ANESTHESIA 
PHASE 3 
Time < hr) 
Variable -l.75a -1 . 5 -lb oc 
USG MEAN 1 .002 1 .010 1 .036 1 .001 
s. E. 0.000 0.003 0.002 0.000 
Osmo MEAN 72 293 1329 74 
S.E. 19 117 89 10 
a=ADH challenge started following this sample. 
b=ADH challenge ended following this sample. 
c=Anesthesia started following this sample. 
0.5 
1 . 017* 
0.004 
505* 
178 
d=Second ADH challenge started following this sample. 
*=Significantly lower than time -1 hr. <p< .05) 
1 
1 . 02 6 * 
0.002 
823 
161 
1.5 
1. 026* 
0.002 
872* 
92 
2d 2.5 
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900 918* 
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3 
1. 026* 
0.002 
974* 
113 
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and Uosm levels during the ADH challenge while anesthetized that 
were equal to preanesthetic ADH challenge values. The urinalyses 
performed following phase 1 and phase 2 did not reveal evidence of 
urinary tract infection. All dogs were able to concentrate to a 
specific gravity of greater than l .047 between phases. 
Serum chemistry profiles run prior to and at 4 hours of anesthesia 
during phase 1 and phase 2 were within norma 1 1 i mits other than the 
serum K+ values previously mentioned. 
Results of the fractional excretions of Na+ and K+ measured during 
phase are given in Table III. There was no statistically 
significant increases in either parameter during the four hours of 
anesthesia and the values were consistent with those previously 
reported for normal dogs. 25 
DISCUSSION 
Induction and maintenance of anesthesia with methoxyflurane in 
dogs during water deprivation was associated with a rapid drop in USG 
and Uosm· This drop was statistically significant in the first 
group of samples examined <after 1 hr of anesthesia) and remained so 
through the four hrs of anesthesia and for 8 hrs post anesthesia. At 
times during anesthesia, some dogs produced urine with a specific 
gravity below 1 .030. Values as low as this could result in an 
erroneous evaluation of the patient's renal function. 2 ' 5 ' 9 The 
response was variable between dogs with one dog dropping to as low as 
1.016, but all dogs showing a significant drop. 
Similarly, urine osmolalities were in the range that could lead to 
misinterpretation. The urine osmolality from all dogs decreased to 
15 
TABLE II I 
FRACTIONAL ECRETIONS* 
Time < hr) 
Variable 0 2 3 4 
Fe Na+ MEAN 0.38 0.29 0.42 0.26 0. 18 
S.E. 0.08 0.07 0. 12 0.09 0.03 
Fe K+ MEAN 9 10.2 15.9 20.8 23 
s. E. 2.4 2. 1 3.5 2.0 3.4 
*Fractional excretions measured during Phase 1 
16 
below 1500 mosm/l by the second hour of anesthesia; one dog's Uosm 
decreased to 413 mosm/L. Hardy and Osborne have suggested that levels 
below 1700 mosm/1, when the animal is mildly dehydrated, may indicate 
nephron dysfunction. 3 Subjectively, the magnitude of decrease in 
USG and Uosm seemed to be positively correlated with the depth of 
anesthesia, however, neither blood nor end expiratory methoxyflurane 
concentrations were measured to confirm this impression. 
The decrease in renal concentrating ability was further supported 
by the response of water loaded dogs to ADH challenge during 
anesthesia. The mean USG produced by anesthetized dogs in response to 
an ADH challenge was lower than the mean USG produced by the same dogs 
in response to an ADH challenge while unanesthetized. 
In phase 2 of the study, the 1 owe red USG was not responsive to 
administration of exogenous ADH indicating that the decreased renal 
concentrating ability was not caused by lowered plasma ADH 
concentrations. Failure of ADH challenge to increase USG and Uosm 
during Phase 3 of the experiment supports this tenant. 
Failure of exogenous ADH to increase urine concentration and the 
anesthesia induced antidiuresis seen in water loaded dogs during phase 
three suggest that ADH release is maximally stimulated during 
methoxyflurane anesthesia. This conclusion is consistent with 
previous studies. 11 - 13 Studies by Deutsch, demonstrated a marked 
antidiuresis and rise in urine osmolality in humans following 
anesthesia with halothane and cyclopropane. 11 - 13 These effects were 
partially reversible upon administration of ethanol suggesting that 
they were mediated, at least in part, by ADH. 11 ' 12 Increased blood 
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levels of ADH have been demonstrated during methoxyflurane 
anesthesia. 13 
Submaximal urine concentration during maximal ADH secretion and/or 
administration suggests the possibility of either decreased binding of 
ADH to its renal receptors, decreased tubular response to ADH binding, 
or decreased renal medullary tonicity. 
Evidence of renal pathology was not found in any of the dogs in 
this study. Renal concentrating ability returned rapidly after each 
anesthetic period and histopathologic lesions were not found in the 
kidney. Fractiona 1 excretion of Na+ and K+ were measured during the 
four hrs of anesthesia of phase l. Fractional excretion of Na+ is a 
measure of tubular handling of sodium which is commonly used in human 
medicine to monitor for acute tubular necrosis. 14 ' 15 Although 
normal ranges are not well established for the dog, the mean values 
obtained in this study were comparable to reported normal values 25 
and no statistically significant increases occurred during the 
anesthetic period. 
These findings suggest that methoxyflurane anesthesia results in a 
consistent, temporary decrease in renal concentrating ability without 
evidence of renal pathology. The magnitude of the concentrating 
defect is sufficient to cause the misdiagnosis of renal disease and 
may possibly be correlated to depth of anesthesia, but this latter 
association was not evaluated. The decreased renal concentrating 
ability is not responsive to exogenous ADH administration. In fact, 
endogenous ADH appears to be maximally stimulated during 
methoxyflurane anesthesia impairing the animal 1 S ability to clear free 
water. Recovery from anesthesia leads to a rapid reversal of impaired 
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renal concentrating ability with USG and Uosm values no longer 
significantly lower than presample values by 24 hrs after cessation of 
anesthesia. The opposing effects of impaired renal concentrating 
ability and stimulation of ADH release probably account for the 
apparently conflicting reports of renal response to methoxyflurane 
anesthesia. 
No attempt was made to determine the mechanism of the renal 
concentrating defect, nor to determine whether the defect was unique 
to methoxyflurane or a result of physiologic changes associated with 
general anesthesia. Most dogs in the study became acidotic and some 
became hypothermic despite attempts to maintain normal body 
temperature. Neither of these conditions is likely to be the sole 
cause of the concentrating defect observed. Rose et a 1., in 1984, 
demonstrated that conscious dogs with hypercapnic acidosis <Pcaz= 
53; pH=7. 19) had no change in Uosm and the free water clearance 
became more negative. 16 11 Cold diuresis" has been reported in humans 
and various animals. 26 ' 27 In rats, exposure to cold ambient 
temperature results in increased urine volume and decreased urine 
osmolality. 26 It was suggested that this diuresis was the result of 
lowered endogenous ADH release secondary to systemic hemodynamic 
responses. 26 One study in dogs demonstrated a decreased ability to 
resorb free water during cold exposure; plasma ADH values in these 
animals were found to be increased. 27 Urine osmolalities were not 
reported. In the present study, a 11 dogs had decreased rena 1 
concentrating ability during anesthesia, but not all of them became 
hypothermic. Also, the urine specific gravity and osmolality were 
still decreased at 8 hours post anesthesia and, although not measured 
19 
post anesthesia, it would be expected that body temperature would have 
returned to normal by this time. 
In humans, it has been well documented that prolonged exposure to 
methoxyflurane anesthesia is associated with a nephrotoxicosis 
characterized by polyuria and polydipsia <PU/PD), decreased renal 
concentrating ability, azotemia and signs of clinical illness. 21 - 24 
This effect was not consistent in all patients. Return of normal 
renal function in affected patients often required several weeks or 
months. The nephrotox i cos is is thought to be media ted through 
liberation of inorganic fluoride ions during metabolism of 
methoxyflurane 22 , and is directly related to the magnitude of 
exposure to methoxyflurane (depth and duration of the anesthesia)-. 22 
Histopathologic examination of kidneys from patients with 
methoxyflurane nephrotoxicity revealed nonspecific renal tubular 
degeneration, interstitial fibrosis, increased numbers of inflammatory 
cells in the interstitium and, sometimes, sheets of calcium oxalate 
crystals within and surrounding the renal tubules. 21 ' 24 
Several studies have attempted to produce methoxyflurane 
nephrotox i cos is in the dog. 1 7 - 2 0 Although the serum inorganic 
fluoride levels reported in the dogs in these studies were equal to or 
higher than those associated with toxicity in humans, no clinical, 
clinicopathologic, or histopathologic evidence of overt renal toxicity 
was documented. 18 ' 19 All of the studies, however, did note a 
transient PU/PD following anesthesia. No evaluation of renal 
concentrating ability <water deprivation or ADH stimulation) was 
performed to determine if the PU/PD resulted from an inability of the 
kidney to conserve water or a primary polydipsia. This polyuria could 
20 
represent a milder form of the toxicity seen in humans, however, it is 
more likely that it is due to an effect of methoxyflurane itself 
rather than a toxic effect of its metabolites. This is suggested by 
the inhibition of vasopressin stimulated water transport seen during 
methoxyflurane exposure in the in vitro studies using toad urinary 
bladders. 10 ' 28 Levine points out that it is unlikely that bladder 
epithelial cells possess the enzyme systems necessary to metabolize 
methoxyflurane to fluoride, furthermore, response of the toad b 1 adder 
epithelium to fluoride exposure is different than the response to 
methoxyflurane exposure. He concluded that it was unlikely that 
accumulation of fluoride played any role in the effects seen in his 
study. 28 If this is true, it is likely that methoxyflurane may cause 
a renal concentrating defect in the mammalian kidney that is distinct 
from the nephrotoxicosis caused by accumulation of its metabolites. 
The results of this study indicate that methoxyflurane anesthesia 
results in both decreased rena 1 concentrating abi 1 i ty and decreased 
free water clearance. The decrease in renal 
could be associated with either decreased 
concentrating ability 
affinity of ADH for 
receptors on the renal collecting ducts, decreased responsiveness of 
the renal collecting ducts following ADH binding to receptors, or 
decreased renal medullary osmolality. The decreased free water 
clearance appears to result from stimulation ·of endogenous ADH 
release. The magnitude of the decrease in renal concentrating ability 
is sufficient to impair accurate evaluation of renal function during 
and immediately following anesthesia. 
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